Australian Operations
Include All CSL Behring Country Sites

Rh(D) Immunoglobulin-VF

Human Anti-D Rh(D) Immunoglobulin

Rh(D) Immunoglobulin-VF (Anti-D) is a human immunoglobulin preparation for intramuscular administration.

Rh(D) Immunoglobulin-VF is prepared from blood obtained from voluntary and non-remunerated (unpaid) donors. Rh(D) Immunoglobulin-VF contains proteins called antibodies which help to suppress the unwanted immune response in an Rh(D) negative woman following her exposure to Rh(D) positive red cells.

For example, if a pregnant woman has an Rh(D) negative blood group and her baby is Rh(D) positive, the baby's blood is incompatible with the mother’s. This could lead to reduced red blood cells, brain damage and other serious complications in the baby. This condition is known as Haemolytic Disease of the Newborn.

Rh(D) Immunoglobulin-VF can be given to Rh(D) negative women during pregnancy and following birth of an Rh(D) positive baby to help prevent Haemolytic Disease of the Newborn.

Rh(D) Immunoglobulin-VF is sometimes given on other occasions when a woman of child-bearing age may become exposed to Rh(D) positive blood: for example, after blood transfusion, amniocentesis (taking a sample of the fluid surrounding the unborn baby), miscarriage or stillbirth.

Rh(D) Immunoglobulin-VF is available only with a doctor’s prescription.

Data sheet
The data sheet contains information to ensure the safe and effective use of a medicine. This document is approved by Medsafe, the New Zealand Medicines and Medical Devices Safety Authority. It is made available by CSL Behring for you if you are a:
  1. qualified healthcare professional; or
  2. consumer wanting further information on the product; and agree to consult with your healthcare professional if you have any questions in relation to the Data sheet.
PDF icon Rh(D) Immunoglobulin-VF Data Sheet (PDF, 0.07 MB)